Breaking News Instant updates and real-time market news.

IPXL

Merged into AMRX

$19.95

-0.85 (-4.09%)

12:54
10/17/17
10/17
12:54
10/17/17
12:54

Impax merger makes strategic sense, says BMO Capital

BMO Capital analyst Gary Nachman believes Impax Laboratories' merger with privately held Amneal makes strategic sense given the challenging generic environment. With Impax's valuation "already stretched," management will execute on the pipeline to drive a greater premium, Nachman tells investors in an intraday research note. He keeps a Market Perform rating on Impax.

  • 09

    Nov

IPXL Merged into AMRX
$19.95

-0.85 (-4.09%)

09/19/17
DBAB
09/19/17
NO CHANGE
Target $23
DBAB
Buy
Impax price target raised to $23 from $20 at Deutsche Bank
Deutsche Bank analyst Gregg Gilbert raised his price target for Impax Laboratories to $23 citing the potential for additional cost savings on a standalone basis. The analyst, while admitting the shares "could take a breather" after rallying 40% since the Q2 earnings call, is optimistic that CEO Paul Bisaro will pursue strategic initiatives to increase shareholder value. He keeps a Buy rating on Impax.
09/27/17
RBCM
09/27/17
NO CHANGE
Target $9
RBCM
Sector Perform
Endo could pursue strategy similar to Impax, says RBC Capital
After The Wall Street Journal's recent report that Impax (IPXL) and Amneal Pharmaceuticals are in talks to combine to better compete in the generic drug market, RBC Capital analyst Randall Stanicky said the activity could shift focus to Endo (ENDP), which he believes could pursue a similar strategy. The analyst, who added that the similarities of Impax and Endo are "striking," but notes Impax shares have outperformed largely on M&A expectations, has a Sector Perform rating on Endo shares.
09/28/17
GSCO
09/28/17
INITIATION
Target $20
GSCO
Neutral
Impax initiated with a Neutral at Goldman Sachs
Goldman analyst Dana Flanders Impax with a Neutral and $20 price target. The analyst sees downside risk to 2018 generic fundamentals given lack of sustainable R&D and said shares trade at a significant premium to peers.
10/17/17
BMOC
10/17/17
NO CHANGE
BMOC
Market Perform
Impax combination with Amneal makes strategic sense, says BMO Capital
BMO Capital analyst Gary Nachman thinks the combination of Impax with Amneal makes strategic sense as the two face a more challenging generic environment. He also believes the valuation of Impax had already been "somewhat stretched" amid news reports and investor speculation that such a deal would be coming. Nachman keeps a Market Perform rating on Impax shares, which are down nearly 9% in midday trading.

TODAY'S FREE FLY STORIES

GS

Goldman Sachs

$229.73

-1.28 (-0.55%)

09:50
07/17/18
07/17
09:50
07/17/18
09:50
Hot Stocks
Breaking Hot Stocks news story on Goldman Sachs »

Goldman Sachs sees 2H…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HFC

HollyFrontier

$68.75

-0.165 (-0.24%)

09:50
07/17/18
07/17
09:50
07/17/18
09:50
Options
Repeat of bullish vertical spreads in HollyFrontier »

Repeat of bullish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

TXT

Textron

$66.80

0.13 (0.19%)

09:49
07/17/18
07/17
09:49
07/17/18
09:49
Technical Analysis
Technical Earnings Preview: Textron near highs before news »

The stock is in a strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

GS

Goldman Sachs

$230.50

-0.51 (-0.22%)

09:48
07/17/18
07/17
09:48
07/17/18
09:48
Hot Stocks
Goldman Sachs CFO says investment banking backlog reached record in Q2 »

Goldman Sachs CFO Marty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:48
07/17/18
07/17
09:48
07/17/18
09:48
Conference/Events
Cowen Internet & new media analyst to hold an analyst/industry conference call »

Internet & New Media…

09:47
07/17/18
07/17
09:47
07/17/18
09:47
General news
Netflix slide leading Nasdaq to struggle at open »

Stock futures fell during…

SERV

ServiceMaster

$61.85

(0.00%)

09:47
07/17/18
07/17
09:47
07/17/18
09:47
Hot Stocks
ServiceMaster falls -5.7% »

ServiceMaster is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

HZN

Horizon Global

$6.89

(0.00%)

09:47
07/17/18
07/17
09:47
07/17/18
09:47
Hot Stocks
Horizon Global falls -6.6% »

Horizon Global is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMC

Omnicom

$72.81

-5.31 (-6.80%)

09:47
07/17/18
07/17
09:47
07/17/18
09:47
Hot Stocks
Omnicom falls -6.9% »

Omnicom is down -6.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 09

    Aug

IGT

International Game

$25.17

0.78 (3.20%)

09:47
07/17/18
07/17
09:47
07/17/18
09:47
Hot Stocks
International Game rises 3.5% »

International Game is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

GOL

Gol Linhas

$6.66

0.27 (4.23%)

09:47
07/17/18
07/17
09:47
07/17/18
09:47
Hot Stocks
Gol Linhas rises 3.8% »

Gol Linhas is up 3.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FPI

Farmland Partners

$6.54

0.445 (7.30%)

09:47
07/17/18
07/17
09:47
07/17/18
09:47
Hot Stocks
Farmland Partners rises 7.0% »

Farmland Partners is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CATM

Cardtronics

$26.60

(0.00%)

09:46
07/17/18
07/17
09:46
07/17/18
09:46
Recommendations
Cardtronics analyst commentary  »

Cardtronics immediate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

09:45
07/17/18
07/17
09:45
07/17/18
09:45
General news
Housing Market Index to be reported at 10:00 »

July Housing Market Index…

09:45
07/17/18
07/17
09:45
07/17/18
09:45
General news
Breaking General news story  »

Federal Reserve Chairman…

CMCSA

Comcast

$34.98

(0.00%)

, CMCSK

Comcast

$0.00

(0.00%)

09:42
07/17/18
07/17
09:42
07/17/18
09:42
Periodicals
NBCU relaunches Craftsy as subscription-video service Bluprint, Variety reports »

NBCUniversal Cable…

CMCSA

Comcast

$34.98

(0.00%)

CMCSK

Comcast

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$124.70

(0.00%)

09:42
07/17/18
07/17
09:42
07/17/18
09:42
Hot Stocks
Johnson & Johnson says 'disappointed' in Spine & Knee medical sales results »

Says Spine still an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 08

    Aug

BA

Boeing

$356.01

(0.00%)

09:41
07/17/18
07/17
09:41
07/17/18
09:41
Hot Stocks
Boeing, Xiamen Airlines announce optimized maintenance program deal »

Boeing and Xiamen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

SNA

Snap-On

$163.93

(0.00%)

09:41
07/17/18
07/17
09:41
07/17/18
09:41
Recommendations
Snap-On analyst commentary  »

Snap-On checks point to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 16

    Aug

VEON

Veon

$3.05

(0.00%)

, HFC

HollyFrontier

$68.91

(0.00%)

09:40
07/17/18
07/17
09:40
07/17/18
09:40
Options
Unusually active option classes on open July 17th »

Unusual total active…

VEON

Veon

$3.05

(0.00%)

HFC

HollyFrontier

$68.91

(0.00%)

DUST

Direxion Daily Gold Miners Bear 3X ETF

$25.49

(0.00%)

UNH

UnitedHealth

$257.03

(0.00%)

JNJ

Johnson & Johnson

$124.70

(0.00%)

CZR

Caesars

$11.63

(0.00%)

GS

Goldman Sachs

$231.01

(0.00%)

MCD

McDonald's

$158.76

(0.00%)

ATVI

Activision Blizzard

$80.23

(0.00%)

GDX

Market Vector Gold Miners

$21.88

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 01

    Aug

  • 02

    Aug

  • 02

    Aug

  • 08

    Aug

NFLX

Netflix

$400.24

4.32 (1.09%)

09:38
07/17/18
07/17
09:38
07/17/18
09:38
Recommendations
Netflix analyst commentary  »

Netflix Q2 weakness is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEX

Wex

$194.01

-2 (-1.02%)

09:36
07/17/18
07/17
09:36
07/17/18
09:36
Initiation
Wex initiated  »

Wex initiated with a Peer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$231.01

4.71 (2.08%)

09:36
07/17/18
07/17
09:36
07/17/18
09:36
Periodicals
Lloyd Blankfein writes farewell memo to Goldman Sachs team, NY Times reports »

Goldman Sachs CEO LLoyd…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVRO

Nevro

$58.79

1.04 (1.80%)

09:35
07/17/18
07/17
09:35
07/17/18
09:35
Recommendations
Nevro analyst commentary  »

Nevro price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

FLT

FleetCor

$216.11

-4.06 (-1.84%)

09:35
07/17/18
07/17
09:35
07/17/18
09:35
Initiation
FleetCor initiated  »

FleetCor initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.